| Case | Age | Parity | Gravidity | GW of FV | PL | NS | GW of D | PB | FW (g) | bacterial morphotypes or culture | MT | note |
| 1 | 39 | 0 | 1 | 10 | + | 4 | 41w2d | 3240 | GBS | penicillin + tocolytics | ||
| 2 | 27 | 2 | 3 | 8 | + | 4 | 39w2d | 3350 | GBS | penicillin + tocolytics | ||
| 3 | 25 | 0 | 0 | 18 | 4 | 41w2d | 3600 | Enterococcus sp. | no therapy | |||
| 4 | 35 | 0 | 0 | 31 | + | 4 | 33w6d | + | 1778 | Bifidobacterium sp. | + | fetal anomaly, polyhydramnios |
| 5 | 36 | 0 | 0 | 21 | + | 4 | 36w5d | + | 2548 | Bifidobacterium sp. | + | ileus of mother |
| 6 | 34 | 1 | 2 | 11 | 4 | 37w2d | 2734 | Bifidobacterium sp. | metronidazole | |||
| 7 | 31 | 1 | 1 | 7 | 4 | 39w0d | 2776 | Bifidobacterium sp. | no therapy | |||
| 8 | 27 | 2 | 2 | 7 | + | 4 | 37w0d | 2892 | Bifidobacterium sp. | metronidazole | ||
| 9 | 35 | 1 | 1 | 12 | 4 | 39w4d | 3126 | Bifidobacterium sp. | metronidazole | |||
| 10 | 28 | 1 | 1 | 7 | 4 | 39w5d | 3194 | Bifidobacterium sp. | no therapy | |||
| 11 | 37 | 0 | 0 | 28 | 4 | 40w0d | 3108 | Bifidobacterium sp. | no therapy | |||
| 12 | 31 | 1 | 1 | 34 | 4 | 40w1d | 2509 | Bifidobacterium sp. | no therapy | |||
| 13 | 27 | 0 | 1 | 36 | 4 | 40w5d | 2608 | Bifidobacterium sp. | no therapy | |||
| 14 | 24 | 0 | 1 | 23 | + | 4 | 24w4d | + | 622 | negative | + | PROM, prophylactic antibiotics + tocolytics |
| 15 | 29 | 0 | 0 | 34 | + | 4 | 34w3d | + | 2284 | negative | + | PROM, prophylactic antibiotics |
| 16 | 30 | 1 | 1 | 35 | + | 4 | 35w2d | + | 2028 | negative | + | PROM, prophylactic antibiotics |
| 17 | 28 | 0 | 0 | 35 | + | 4 | 35w6d | + | 1488 | negative | + | PROM, prophylactic antibiotics |
| 18 | 35 | 0 | 0 | 36 | + | 4 | 36w6d | + | 1955 | negative | + | PROM + IUGR, prophylactic antibiotics |
| 19 | 28 | 1 | 2 | 34 | 4 | 38w4d | 3240 | negative | + | PROM, prophylactic antibiotics | ||
| 20 | 35 | 1 | 1 | 27 | + | 4 | unclear | unclear | negative | + | transferred to previous HP |